Advertisement

Index by Author

June 1999; 48 (6)
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z

A

  1. Ashcroft, F M

    • Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel. Diabetes June 1999 48:1341-1347; doi:10.2337/diabetes.48.6.1341

  2. Ashcroft, S J

    • Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel. Diabetes June 1999 48:1341-1347; doi:10.2337/diabetes.48.6.1341

  3. Ashfield, R

    • Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel. Diabetes June 1999 48:1341-1347; doi:10.2337/diabetes.48.6.1341

  4. Avogaro, A

    • Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes June 1999 48:1316-1322; doi:10.2337/diabetes.48.6.1316

  5. Axelin, T

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245

B

  1. Barucci, N

    • Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes June 1999 48:1270-1274; doi:10.2337/diabetes.48.6.1270

  2. Baumgartner-Parzer, S

    • Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes June 1999 48:1331-1337; doi:10.2337/diabetes.48.6.1331

  3. Beck-Nielsen, H

    • Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes June 1999 48:1258-1263; doi:10.2337/diabetes.48.6.1258

  4. Bell, K

    • Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes June 1999 48:1270-1274; doi:10.2337/diabetes.48.6.1270

  5. Bergman, J

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245

  6. Bertuzzi, F

    • Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes June 1999 48:1230-1236; doi:10.2337/diabetes.48.6.1230

  7. Beylot, M

    • Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin. Diabetes June 1999 48:1251-1257; doi:10.2337/diabetes.48.6.1251

  8. Brownlee, M

    • Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes June 1999 48:1223-1229; doi:10.2337/diabetes.48.6.1223

  9. Brun, S

    • Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes June 1999 48:1217-1222; doi:10.2337/diabetes.48.6.1217

  10. Burcelin, R

    • Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes June 1999 48:1264-1269; doi:10.2337/diabetes.48.6.1264

C

  1. Campeau, L

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

  2. Canner, J

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

  3. Capristo, E

    • Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes June 1999 48:1258-1263; doi:10.2337/diabetes.48.6.1258

  4. Carmona, M C

    • Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes June 1999 48:1217-1222; doi:10.2337/diabetes.48.6.1217

  5. Castagneto, M

    • Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes June 1999 48:1258-1263; doi:10.2337/diabetes.48.6.1258

  6. Ceolotto, G

    • Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes June 1999 48:1316-1322; doi:10.2337/diabetes.48.6.1316

  7. Cerasi, E

    • Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes June 1999 48:1230-1236; doi:10.2337/diabetes.48.6.1230

  8. Chan, A

    • A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes June 1999 48:1338-1340; doi:10.2337/diabetes.48.6.1338

  9. Charron, M J

    • Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes June 1999 48:1264-1269; doi:10.2337/diabetes.48.6.1264

  10. Cline, G W

    • Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes June 1999 48:1270-1274; doi:10.2337/diabetes.48.6.1270

  11. Cressman, M

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

D

  1. De Haan, C H

    • Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes June 1999 48:1300-1307; doi:10.2337/diabetes.48.6.1300

  2. De Leeuw, P W

    • Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes June 1999 48:1300-1307; doi:10.2337/diabetes.48.6.1300

  3. Del Prato, S

    • Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes June 1999 48:1316-1322; doi:10.2337/diabetes.48.6.1316

  4. Domanski, M

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

  5. Donaghue, K

    • A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes June 1999 48:1338-1340; doi:10.2337/diabetes.48.6.1338

E

  1. Edelstein, D

    • Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes June 1999 48:1223-1229; doi:10.2337/diabetes.48.6.1223

  2. Esenabhalu, V E

    • Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution. Diabetes June 1999 48:1323-1330; doi:10.2337/diabetes.48.6.1323

F

  1. Ferrannini, E

    • Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes June 1999 48:1258-1263; doi:10.2337/diabetes.48.6.1258

  2. Fleischhacker, E

    • Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution. Diabetes June 1999 48:1323-1330; doi:10.2337/diabetes.48.6.1323

  3. Friedman, J M

    • Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes June 1999 48:1264-1269; doi:10.2337/diabetes.48.6.1264

G

  1. Gallo, A

    • Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes June 1999 48:1316-1322; doi:10.2337/diabetes.48.6.1316

  2. Gasbarrini, G

    • Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes June 1999 48:1258-1263; doi:10.2337/diabetes.48.6.1258

  3. Gastaldelli, A

    • Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes June 1999 48:1258-1263; doi:10.2337/diabetes.48.6.1258

  4. Geller, N

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

  5. Giralt, M

    • Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes June 1999 48:1217-1222; doi:10.2337/diabetes.48.6.1217

  6. Goodyear, L J

    • Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes June 1999 48:1270-1274; doi:10.2337/diabetes.48.6.1270

  7. Graier, W F

    • Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution. Diabetes June 1999 48:1323-1330; doi:10.2337/diabetes.48.6.1323
    • Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes June 1999 48:1331-1337; doi:10.2337/diabetes.48.6.1331

  8. Greco, A V

    • Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes June 1999 48:1258-1263; doi:10.2337/diabetes.48.6.1258

  9. Gribble, F M

    • Identification of the high-affinity tolbutamide site on the SUR1 subunit of the K(ATP) channel. Diabetes June 1999 48:1341-1347; doi:10.2337/diabetes.48.6.1341

  10. Griffin, M E

    • Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes June 1999 48:1270-1274; doi:10.2337/diabetes.48.6.1270

  11. Gross, D J

    • Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes June 1999 48:1230-1236; doi:10.2337/diabetes.48.6.1230

H

  1. Haaparanta, M

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245

  2. Hämäläinen, H

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245

  3. Hamulyak, K

    • Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes June 1999 48:1300-1307; doi:10.2337/diabetes.48.6.1300

  4. Hartikainen, J E

    • Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes June 1999 48:1295-1299; doi:10.2337/diabetes.48.6.1295

  5. Havel, P J

    • Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes June 1999 48:1275-1280; doi:10.2337/diabetes.48.6.1275

  6. He, C

    • Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. Diabetes June 1999 48:1308-1315; doi:10.2337/diabetes.48.6.1308

  7. Henriksen, F L

    • Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes June 1999 48:1258-1263; doi:10.2337/diabetes.48.6.1258

  8. Herd, A

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

  9. Hickey, A

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

  10. Hirayama, I

    • Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes June 1999 48:1237-1244; doi:10.2337/diabetes.48.6.1237

  11. Holzmann, S

    • Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution. Diabetes June 1999 48:1323-1330; doi:10.2337/diabetes.48.6.1323

  12. Hoogwerf, B J

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

  13. Houben, A J

    • Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes June 1999 48:1300-1307; doi:10.2337/diabetes.48.6.1300

  14. Hunninghake, D B

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

  15. Huvers, F C

    • Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes June 1999 48:1300-1307; doi:10.2337/diabetes.48.6.1300

I

  1. Iglesias, R

    • Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes June 1999 48:1217-1222; doi:10.2337/diabetes.48.6.1217

  2. Iida, H

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245

  3. Izumi, T

    • Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes June 1999 48:1237-1244; doi:10.2337/diabetes.48.6.1237

J

  1. Ju, Q

    • Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes June 1999 48:1223-1229; doi:10.2337/diabetes.48.6.1223

  2. Jürgens, G

    • Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes June 1999 48:1331-1337; doi:10.2337/diabetes.48.6.1331

K

  1. Kaiser, N

    • Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes June 1999 48:1230-1236; doi:10.2337/diabetes.48.6.1230

  2. Kamohara, S

    • Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes June 1999 48:1264-1269; doi:10.2337/diabetes.48.6.1264

  3. Kao, Y L

    • A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes June 1999 48:1338-1340; doi:10.2337/diabetes.48.6.1338

  4. Klip, A

    • Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle. Diabetes June 1999 48:1281-1288; doi:10.2337/diabetes.48.6.1281

  5. Knatterud, G L

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

  6. Knight, J

    • A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes June 1999 48:1338-1340; doi:10.2337/diabetes.48.6.1338

  7. Knuuti, J

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245

  8. Koidl, B

    • Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution. Diabetes June 1999 48:1323-1330; doi:10.2337/diabetes.48.6.1323

  9. Korbutt, G S

    • Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes June 1999 48:1223-1229; doi:10.2337/diabetes.48.6.1223

  10. Kostner, G M

    • Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution. Diabetes June 1999 48:1323-1330; doi:10.2337/diabetes.48.6.1323
    • Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes June 1999 48:1331-1337; doi:10.2337/diabetes.48.6.1331

  11. Kraegen, E W

    • Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes June 1999 48:1270-1274; doi:10.2337/diabetes.48.6.1270

  12. Krogh, L N

    • Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes June 1999 48:1258-1263; doi:10.2337/diabetes.48.6.1258

  13. Kubo, S K

    • Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes June 1999 48:1237-1244; doi:10.2337/diabetes.48.6.1237

  14. Kuwano, H

    • Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes June 1999 48:1237-1244; doi:10.2337/diabetes.48.6.1237

L

  1. Laakso, M

    • Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes June 1999 48:1295-1299; doi:10.2337/diabetes.48.6.1295

  2. Laitinen, T

    • Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes June 1999 48:1295-1299; doi:10.2337/diabetes.48.6.1295

  3. Länsimies, E A

    • Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes June 1999 48:1295-1299; doi:10.2337/diabetes.48.6.1295

  4. Large, V

    • Modifications of citric acid cycle activity and gluconeogenesis in streptozotocin-induced diabetes and effects of metformin. Diabetes June 1999 48:1251-1257; doi:10.2337/diabetes.48.6.1251

  5. Lee, D

    • Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes June 1999 48:1270-1274; doi:10.2337/diabetes.48.6.1270

  6. Leibowitz, G

    • Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes June 1999 48:1230-1236; doi:10.2337/diabetes.48.6.1230

  7. Li, J

    • Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes June 1999 48:1264-1269; doi:10.2337/diabetes.48.6.1264

  8. Luotolahti, M

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245

M

  1. Mäki, M

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245

  2. Mampel, T

    • Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes June 1999 48:1217-1222; doi:10.2337/diabetes.48.6.1217

  3. Marcucci, M J

    • Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes June 1999 48:1270-1274; doi:10.2337/diabetes.48.6.1270

  4. Marshak, S

    • Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes June 1999 48:1230-1236; doi:10.2337/diabetes.48.6.1230

  5. Mathoo, J M

    • Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle. Diabetes June 1999 48:1281-1288; doi:10.2337/diabetes.48.6.1281

  6. Melloul, D

    • Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes June 1999 48:1230-1236; doi:10.2337/diabetes.48.6.1230

  7. Mingrone, G

    • Triglyceride-induced diabetes associated with familial lipoprotein lipase deficiency. Diabetes June 1999 48:1258-1263; doi:10.2337/diabetes.48.6.1258

  8. Miola, M

    • Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes June 1999 48:1316-1322; doi:10.2337/diabetes.48.6.1316

  9. Mitsuhashi, T

    • Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. Diabetes June 1999 48:1308-1315; doi:10.2337/diabetes.48.6.1308

N

  1. Nagamachi, Y

    • Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes June 1999 48:1237-1244; doi:10.2337/diabetes.48.6.1237

  2. Niskanen, L K

    • Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes June 1999 48:1295-1299; doi:10.2337/diabetes.48.6.1295

  3. Nuutila, P

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245

P

  1. Posch, K

    • Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes June 1999 48:1331-1337; doi:10.2337/diabetes.48.6.1331

R

  1. Rabinovitch, A

    • Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes June 1999 48:1223-1229; doi:10.2337/diabetes.48.6.1223

  2. Rajotte, R V

    • Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes June 1999 48:1223-1229; doi:10.2337/diabetes.48.6.1223

S

  1. Sabol, J

    • Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. Diabetes June 1999 48:1308-1315; doi:10.2337/diabetes.48.6.1308

  2. Sartori, M

    • Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes June 1999 48:1316-1322; doi:10.2337/diabetes.48.6.1316

  3. Schaper, N C

    • Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes June 1999 48:1300-1307; doi:10.2337/diabetes.48.6.1300

  4. Schouten, H

    • Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes June 1999 48:1300-1307; doi:10.2337/diabetes.48.6.1300

  5. Schwartz, M W

    • Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes June 1999 48:1275-1280; doi:10.2337/diabetes.48.6.1275

  6. Seeley, R J

    • Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes June 1999 48:1275-1280; doi:10.2337/diabetes.48.6.1275

  7. Semplicini, A

    • Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes June 1999 48:1316-1322; doi:10.2337/diabetes.48.6.1316

  8. Shi, Z Q

    • Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle. Diabetes June 1999 48:1281-1288; doi:10.2337/diabetes.48.6.1281

  9. Shulman, G I

    • Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes June 1999 48:1270-1274; doi:10.2337/diabetes.48.6.1270

  10. Silink, M

    • A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes. Diabetes June 1999 48:1338-1340; doi:10.2337/diabetes.48.6.1338

  11. Simecek, S

    • Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes June 1999 48:1331-1337; doi:10.2337/diabetes.48.6.1331

  12. Sindelar, D K

    • Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes June 1999 48:1275-1280; doi:10.2337/diabetes.48.6.1275

  13. Skrabal, F

    • Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution. Diabetes June 1999 48:1323-1330; doi:10.2337/diabetes.48.6.1323

  14. Socci, C

    • Impaired beta-cell functions induced by chronic exposure of cultured human pancreatic islets to high glucose. Diabetes June 1999 48:1230-1236; doi:10.2337/diabetes.48.6.1230

  15. Spitaler, M

    • Human diabetes is associated with hyperreactivity of vascular smooth muscle cells due to altered subcellular Ca2+ distribution. Diabetes June 1999 48:1323-1330; doi:10.2337/diabetes.48.6.1323

  16. Strynadka, K

    • Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes June 1999 48:1223-1229; doi:10.2337/diabetes.48.6.1223

  17. Suarez-Pinzon, W

    • Transfection of human pancreatic islets with an anti-apoptotic gene (bcl-2) protects beta-cells from cytokine-induced destruction. Diabetes June 1999 48:1223-1229; doi:10.2337/diabetes.48.6.1223

T

  1. Takala, T O

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245

  2. Takeuchi, T

    • Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes June 1999 48:1237-1244; doi:10.2337/diabetes.48.6.1237

  3. Tamemoto, H

    • Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes June 1999 48:1237-1244; doi:10.2337/diabetes.48.6.1237

  4. Tannenbaum, G S

    • Acute intravenous leptin infusion increases glucose turnover but not skeletal muscle glucose uptake in ob/ob mice. Diabetes June 1999 48:1264-1269; doi:10.2337/diabetes.48.6.1264

  5. Trevisan, R

    • Protein kinase C activity is acutely regulated by plasma glucose concentration in human monocytes in vivo. Diabetes June 1999 48:1316-1322; doi:10.2337/diabetes.48.6.1316

  6. Turpeinen, A K

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245

U

  1. Uusitupa, M I

    • Impaired free fatty acid uptake in skeletal muscle but not in myocardium in patients with impaired glucose tolerance: studies with PET and 14(R,S)-[18F]fluoro-6-thia-heptadecanoic acid. Diabetes June 1999 48:1245-1250; doi:10.2337/diabetes.48.6.1245
    • Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes June 1999 48:1295-1299; doi:10.2337/diabetes.48.6.1295

V

  1. Vauhkonen, I K

    • Power spectral analysis of heart rate variability during hyperinsulinemia in nondiabetic offspring of type 2 diabetic patients: evidence for possible early autonomic dysfunction in insulin-resistant subjects. Diabetes June 1999 48:1295-1299; doi:10.2337/diabetes.48.6.1295

  2. Villarroya, F

    • Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes June 1999 48:1217-1222; doi:10.2337/diabetes.48.6.1217

  3. Viñas, O

    • Activators of peroxisome proliferator-activated receptor-alpha induce the expression of the uncoupling protein-3 gene in skeletal muscle: a potential mechanism for the lipid intake-dependent activation of uncoupling protein-3 gene expression at birth. Diabetes June 1999 48:1217-1222; doi:10.2337/diabetes.48.6.1217

  4. Vlassara, H

    • Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration. Diabetes June 1999 48:1308-1315; doi:10.2337/diabetes.48.6.1308

  5. Vranic, M

    • Opposite effects of acute hypoglycemia and acute hyperglycemia on glucose transport and glucose transporters in perfused rat skeletal muscle. Diabetes June 1999 48:1281-1288; doi:10.2337/diabetes.48.6.1281

W

  1. Waness, A

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

  2. Wang, J

    • Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes June 1999 48:1237-1244; doi:10.2337/diabetes.48.6.1237

  3. Wascher, T C

    • Glycated low-density lipoprotein attenuates shear stress-induced nitric oxide synthesis by inhibition of shear stress-activated L-arginine uptake in endothelial cells. Diabetes June 1999 48:1331-1337; doi:10.2337/diabetes.48.6.1331

  4. White, C

    • Effects of aggressive cholesterol lowering and low-dose anticoagulation on clinical and angiographic outcomes in patients with diabetes: the Post Coronary Artery Bypass Graft Trial. Diabetes June 1999 48:1289-1294; doi:10.2337/diabetes.48.6.1289

  5. White, M F

    • Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes June 1999 48:1270-1274; doi:10.2337/diabetes.48.6.1270

  6. Wilkinson, C W

    • Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes June 1999 48:1275-1280; doi:10.2337/diabetes.48.6.1275

  7. Wolffenbuttel, B H

    • Endothelium-dependent vasodilatation, plasma markers of endothelial function, and adrenergic vasoconstrictor responses in type 1 diabetes under near-normoglycemic conditions. Diabetes June 1999 48:1300-1307; doi:10.2337/diabetes.48.6.1300

  8. Woods, S C

    • Low plasma leptin levels contribute to diabetic hyperphagia in rats. Diabetes June 1999 48:1275-1280; doi:10.2337/diabetes.48.6.1275

Y

  1. Yokota, H

    • Insulin receptor-related receptor is expressed in pancreatic beta-cells and stimulates tyrosine phosphorylation of insulin receptor substrate-1 and -2. Diabetes June 1999 48:1237-1244; doi:10.2337/diabetes.48.6.1237

Current Issue

  1. February 2012, 61 (2)
  1. Current Issue
  1. Alert me to new issues of Diabetes
Advertisement